CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. - Pampusch, Mary S.; Abdelaal, Hadia M.; Cartwright, Emily K.; Molden, Jhomary S.; Davey, Brianna C.; Sauve, Jordan D.; Sevcik, Emily N.; Rendahl, Aaron K.; Rakasz, Eva G.; Connick, Elizabeth; Berger, Edward A.; Skinner, Pamela J. (PLoS Pathogens, 2022)